Development in the metabolism of dopamine and its derivatives. Application to gross development disorders (Q41127544)

reason for deprecated rank

27 September 2017

title

Évolution du métabolisme de la dopamine et de ses dérivés au cours du développement. Application aux troubles globaux du développement (French)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0987-7053(05)80753-1

reason for deprecated rank

18 October 2022

Development in the metabolism of dopamine and its derivatives. Application to gross development disorders (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0987-7053(05)80753-1

18 October 2022

author name string

Barthélémy C

3

1 reference

27 September 2017

J. Martineau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

B. Garreau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

C. Barthélémy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

J. Jouve

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

G. Lelord

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1630417

18 October 2022

language of work or name

French

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1630417

18 October 2022

publication date

1 June 1992

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:S0987705305807531?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0987-7053(05)80753-1

https://api.elsevier.com/content/article/PII:S0987705305807531?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0987-7053(05)80753-1

Neurophysiologie Clinique

18 October 2022

published in

1 reference

27 September 2017

volume

22

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

179-189

1 reference

Use of bioclinical markers for the assessment and treatment of children with pervasive developmental disorders

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Urinary free and conjugated catecholamines and metabolites in autistic children

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

A neurological model for childhood autism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal gluid HVA in the monkey and its pharmacokinetic disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Behavior and circulating catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Childhood psychosis and monoamine metabolites in spinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Monoamine oxidase and catechol-O-methyltransferase activities in cultured fibroblasts and blood cells from children with autism and the Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Determination of urinary serotonin using liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Biochemistry of the Augmenting-Reducing Response in Visual Evoked Potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Increased Norepinephrine Levels and Decreased Dopamine-β-Hydroxylase Activity in Primary Autism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

A direct method for determining dopamine synthesis and output of dopamine metabolites from brain in awake animals

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Estimates of Dopamine and Serotonin Synthesis by the Awake Human Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Neurochemical study of dopamine functioning in autistic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Central catecholamine neuron systems: anatomy and physiology of the dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

The functional neuroanatomy of infantile autism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long-term effects on the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Evoked potential studies of brain catecholamine alterations in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Determination of catecholamines in urine by reverse-phase liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Evidence that monoamines influence human evoked potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Gas chromatographic determination of urinary vanilglycolic acid, vanilglycol, vanilacetic acid and vanillactic acid — Chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Clinical neurochemistry of autism and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Assessment of Brain Function in Clinical Pediatric Research: Behavioral and Biological Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2805%2980753-1

7 January 2021

Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine

39

1 reference

https://api.crossref.org/works/10.1016/S0987-7053(05)80753-1

18 October 2022

Identifiers

1 reference

27 September 2017

1 reference